Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization. - Wikidata - wikimedia - TriplyDB

Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.

Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.

http://www.wikidata.org/entity/Q33568561

about

Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.Improving perinatal Group B streptococcus screening with process indicators.ANTIMICROBIAL SUSCEPTIBILITY OF Streptococcus agalactiae ISOLATED FROM PREGNANT WOMEN.2010 perinatal GBS prevention guideline and resource utilization.Increased adherence to prenatal group B streptococcal screening guidelines through a paired electronic reminder and education intervention.Recurrence of group B streptococcus colonization in successive pregnancies.Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis.

P2860

Q30457467-95FE54AC-077D-4E3C-B3B8-5A9AD02C2061 Q34171416-1F5A3BC8-8FF3-4357-88C3-162FDC82F9D8 Q37395393-E52D098A-8BF8-430D-A792-7DB5AB29A861 Q37522924-791752B7-A15F-4336-AFD3-4AA0A401BA06 Q38082368-3BB0A384-CB13-4DE0-9613-533AA478FE59 Q41698369-C3EF0F24-CE96-4060-821A-A3166A0929FC Q47556034-F993B909-944B-43E5-A693-3CF055400D74

P2860

Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.

http://www.wikidata.org/entity/Q33568561

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cost-effectiveness of universa ...... p B streptococci colonization.

@ast

Cost-effectiveness of universa ...... p B streptococci colonization.

@en

Cost-effectiveness of universa ...... p B streptococci colonization.

@nl

type

label

Cost-effectiveness of universa ...... p B streptococci colonization.

@ast

Cost-effectiveness of universa ...... p B streptococci colonization.

@en

Cost-effectiveness of universa ...... p B streptococci colonization.

@nl

prefLabel

Cost-effectiveness of universa ...... p B streptococci colonization.

@ast

Cost-effectiveness of universa ...... p B streptococci colonization.

@en

Cost-effectiveness of universa ...... p B streptococci colonization.

@nl

P1433

Q33568561-1F47B31A-6EAB-4417-9452-291B687383BB

P1476

Q33568561-25D29E58-5778-4466-8B58-B164584EB614

P2093

Q33568561-1956186B-D608-4DEB-8E54-509DFABC0935

Q33568561-4C80A0A6-C240-4F77-8D11-9C42D85000F4

Q33568561-D341610C-6EE3-4A37-ABF0-7B53BBDE4ADE

P2860

Q33568561-0D999ABE-B416-4D31-BD19-5A20EE8C3A45

Q33568561-0F920846-E722-40DF-8164-4D2960557537

Q33568561-16CEE7A5-E55A-4AA3-94CD-7F805561EE1B

Q33568561-270EBDE6-6067-4B24-82A0-E8B1B5DF8704

Q33568561-2A98B8BB-356D-4E33-8504-621F9B8D2B14

Q33568561-2F214C5D-F589-40BB-862B-DB25D83FCEAB

Q33568561-30585502-6949-4C99-91DE-8F6435BA8E3C

Q33568561-45010DA7-5E76-4E87-9E7D-6546C31C0EC4

Q33568561-484D20F5-806A-46F5-AF18-7E2804175274

Q33568561-49B8224D-B6DC-4669-8FFC-62ABC8E42A4C

P304

Q33568561-E3B9B902-2FFA-4B75-87BC-205D659EDDB9

P31

Q33568561-940F7553-FCBE-422B-A143-0556CDED58B6

P356

Q33568561-6C087AB0-B95D-4632-939C-7925AFDEA145

P478

Q33568561-B9D41928-6A58-4C01-83EF-EB84D68E494E

P577

Q33568561-226FAEF3-7990-4ED4-972E-FFC9E944CFE5

P5875

Q33568561-9DA94ED6-09BD-4F89-98BD-2305BC0F0912

P698

Q33568561-8407C89D-165E-4BE9-B37A-9A923B777957

P932

Q33568561-7B980A03-EE97-4808-A7EF-9D78E8E6D265

P356

P1433

Infectious Diseases in Obstetrics and Gynecology

P1476

Cost-effectiveness of universa ...... p B streptococci colonization.

@en

P2093

Joan M Mastrobattista

http://www.w3.org/2001/XMLSchema#string

Mark A Turrentine

http://www.w3.org/2001/XMLSchema#string

Mildred M Ramirez

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use

Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock.

Births: final data for 2004.

National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data.

Births: final data for 2005.

Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics.

Current methods of the US Preventive Services Task Force: a review of the process.

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn.

P304

934698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2009/934698

http://www.w3.org/2001/XMLSchema#string

P478

2009

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40851213

http://www.w3.org/2001/XMLSchema#string

P698

20052397

http://www.w3.org/2001/XMLSchema#string

P932

2801019

http://www.w3.org/2001/XMLSchema#string